Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer…

Amount: Not stated
Type: Grant

Key facts

Key facts for Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Amount	Not stated
Issuer	National Institutes of Health
Who can apply	US companies
Sectors	EdTech · HealthTech
Deadline	Closes 14 Oct 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked yesterday

40 days agoagentImported from the official source

Opportunities with the same funding type or region
AI Growth Lab		Closes 27 Sep 2026
BJA FY 2026 Adult Treatment Court Program	up to $2.5M	Closes 30 Oct 2026
BJA FY 2026 Capital Case Litigation Initiative: Improving the Quality of Legal Representation in State Capital Cases	up to $450,000	Closes 29 Oct 2026